Jongwook Oh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jongwook Oh has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Tae-Gyun Kim
Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine
4 shared publications - Do Young Kim
Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea
2 shared publications - Dongsik Bang
Department of Dermatology, Catholic Kwandong University International St. Mary’s Hospital, Incheon, Korea
2 shared publications - Heon Yung Gee
Department of Pharmacology, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea
2 shared publications - Min-Geol Lee
Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea
2 shared publications - Sang Ho Oh
Department of Dermatology and Cutaneous Biology Research Institute, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 22 May 2026
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
Evolving trends and outcomes in living and deceased donor liver transplantation: institutional experience from Changwon Hanmaeum Hospital (2023–2025)
Deny Budiman, Chong Woo Chu, Jongwook Oh, Jeong Hee Kang. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.25.0070
- 22 May 2026
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
Open AccessEvolving trends and outcomes in living and deceased donor liver transplantation: institutional experience from Changwon Hanmaeum Hospital (2023–2025)
Deny Budiman, Chong Woo Chu, Jongwook Oh, Jeong Hee Kang. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.25.0070
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Dermatology
- Vol. 38 (3) , 159-166
Segmental Vitiligo and Somatic Mosaicism: From Pathogenesis to Therapeutics
Oh J, et al. Ann Dermatol. 2026 Jun;38(3):159-166. https://doi.org/10.5021/ad.25.250
- 1 January 2026
- Published by XMLink in Annals of Dermatology
- Vol. 38 (3) , 159-166
Open AccessSegmental Vitiligo and Somatic Mosaicism: From Pathogenesis to Therapeutics
Oh J, et al. Ann Dermatol. 2026 Jun;38(3):159-166. https://doi.org/10.5021/ad.25.250
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Dermatology
- Vol. 38 (1) , 1-10
Refining Nail Surgery: Clinical Pearls and Best Practices
Jung JW, et al. Ann Dermatol. 2025 Nov;38:e11. https://doi.org/10.5021/ad.25.051
- 1 January 2026
- Published by XMLink in Annals of Dermatology
- Vol. 38 (1) , 1-10
Open AccessRefining Nail Surgery: Clinical Pearls and Best Practices
Jung JW, et al. Ann Dermatol. 2025 Nov;38:e11. https://doi.org/10.5021/ad.25.051
- Open Access
- 1 January 2024
- Published by XMLink in Annals of Dermatology
- Vol. 36 (6) , 367-375
Biomarkers for Short-Term Omalizumab Response in Chronic Spontaneous Urticaria
Kim W, et al. Ann Dermatol. 2024 Jun;36:e50. https://doi.org/10.5021/ad.24.004
- 1 January 2024
- Published by XMLink in Annals of Dermatology
- Vol. 36 (6) , 367-375
Open AccessBiomarkers for Short-Term Omalizumab Response in Chronic Spontaneous Urticaria
Kim W, et al. Ann Dermatol. 2024 Jun;36:e50. https://doi.org/10.5021/ad.24.004
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (19) , e156
Anchorage Dependence and Cancer Metastasis
Lee DK, et al. J Korean Med Sci. 2024 May;39(19):e156. https://doi.org/10.3346/jkms.2024.39.e156
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (19) , e156
Open AccessAnchorage Dependence and Cancer Metastasis
Lee DK, et al. J Korean Med Sci. 2024 May;39(19):e156. https://doi.org/10.3346/jkms.2024.39.e156
- Open Access
Increased Risk of Renal Malignancy in Patients with Moderate to Severe Atopic Dermatitis
Background: Evidence for an association between atopic dermatitis (AD) and cancer is still insufficient. In particular, the association between the risk of renal malignancy and the severity of AD has not been thoroughly investigated. Objective: To investigate the risk of renal malignancy and determine the association between AD severity and cancer risk using data from the Korean National Health Insurance Service (KNHIS) database. Methods: We performed a population-based cohort study using the National Health Claims database from the NHIS in Korea. Results: We found a statistically significant association between AD and overall malignancy (for mild AD, hazard ratio (HR): 1.061, 95% confidence interval (CI): 1.006–1.118; for moderate to severe AD, HR: 1.061, 95% CI: 1.014–1.11) compared with the no AD group. The moderate to severe AD group showed a significantly increased risk for renal malignancy (adjusted HR: 1.533, 95% CI: 1.209–1.944) compared with the no AD group. Limitations: Patient inclusion is solely based on diagnostic codes. We had no data about drug use, genetic factors, or other medical history that could affect the cancer risk. Conclusion: In our large population-based cohort study, moderate to severe AD was associated with increased risk of renal malignancy. Regular check-ups for renal malignancy are recommended in this population.
Open AccessIncreased Risk of Renal Malignancy in Patients with Moderate to Severe Atopic Dermatitis
Background: Evidence for an association between atopic dermatitis (AD) and cancer is still insufficient. In particular, the association between the risk of renal malignancy and the severity of AD has not been thoroughly investigated. Objective: To investigate the risk of renal malignancy and determine the association between AD severity and cancer risk using data from the Korean National Health Insurance Service (KNHIS) database. Methods: We performed a population-based cohort study using the National Health Claims database from the NHIS in Korea. Results: We found a statistically significant association between AD and overall malignancy (for mild AD, hazard ratio (HR): 1.061, 95% confidence interval (CI): 1.006–1.118; for moderate to severe AD, HR: 1.061, 95% CI: 1.014–1.11) compared with the no AD group. The moderate to severe AD group showed a significantly increased risk for renal malignancy (adjusted HR: 1.533, 95% CI: 1.209–1.944) compared with the no AD group. Limitations: Patient inclusion is solely based on diagnostic codes. We had no data about drug use, genetic factors, or other medical history that could affect the cancer risk. Conclusion: In our large population-based cohort study, moderate to severe AD was associated with increased risk of renal malignancy. Regular check-ups for renal malignancy are recommended in this population.
- 1 April 2023
- Published by Wiley in The Journal of Dermatology
- Vol. 50 (8) , 1081-1083
Elevated serum IgE levels are not associated with poor treatment outcome in psoriasis vulgaris
Psoriasis is a chronic inflammatory disorder which is associated with impaired skin barrier function. In this context, it was shown that serum IgE level was elevated in significant proportion of psoriasis patients. However, whether serum IgE levels are associated with treatment outcomes of psoriasis has not been understood. We retrospectively analyzed psoriasis patients who visited our clinics through electromedical records. Patients with history of atopic dermatitis were excluded. Total of 483 patients clinically or pathologically diagnosed with psoriasis vulgaris were included for analyses. Initial mean serum IgE level was 226 +/- 490.3 KU/L and patients with IgE higher than upper limit normal value were 42.0% (n = 203). Psoriasis Area and Severity Index (PASI) 75 achievement rate according to IgE elevation was analyzed and no statistically meaningful difference was shown. In addition, logistic regression analysis to find out relationship between PASI 75 achievement and IgE titer also failed to show statistically significant relationship. In conclusion, serum IgE level was elevated in significant proportion in the patients with psoriasis, but its elevated level was not associated with treatment outcome.
- 1 April 2023
- Published by Wiley in The Journal of Dermatology
- Vol. 50 (8) , 1081-1083
Elevated serum IgE levels are not associated with poor treatment outcome in psoriasis vulgaris
Psoriasis is a chronic inflammatory disorder which is associated with impaired skin barrier function. In this context, it was shown that serum IgE level was elevated in significant proportion of psoriasis patients. However, whether serum IgE levels are associated with treatment outcomes of psoriasis has not been understood. We retrospectively analyzed psoriasis patients who visited our clinics through electromedical records. Patients with history of atopic dermatitis were excluded. Total of 483 patients clinically or pathologically diagnosed with psoriasis vulgaris were included for analyses. Initial mean serum IgE level was 226 +/- 490.3 KU/L and patients with IgE higher than upper limit normal value were 42.0% (n = 203). Psoriasis Area and Severity Index (PASI) 75 achievement rate according to IgE elevation was analyzed and no statistically meaningful difference was shown. In addition, logistic regression analysis to find out relationship between PASI 75 achievement and IgE titer also failed to show statistically significant relationship. In conclusion, serum IgE level was elevated in significant proportion in the patients with psoriasis, but its elevated level was not associated with treatment outcome.
- Open Access
- 1 January 2022
- Published by XMLink in Annals of Dermatology
- Vol. 34 (1) , 22-27
Safety, Efficacy, and Drug Survival of Colchicine in Recurrent Aphthous Stomatitis in a Real-World Setting
Oh J, et al. Ann Dermatol. 2022 Feb;34(1):22-27. https://doi.org/10.5021/ad.2022.34.1.22
- 1 January 2022
- Published by XMLink in Annals of Dermatology
- Vol. 34 (1) , 22-27
Open AccessSafety, Efficacy, and Drug Survival of Colchicine in Recurrent Aphthous Stomatitis in a Real-World Setting
Oh J, et al. Ann Dermatol. 2022 Feb;34(1):22-27. https://doi.org/10.5021/ad.2022.34.1.22
- 30 August 2021
- Published by Wiley in The Journal of Dermatology
- Vol. 48 (11) , 1763-1771
Risk of psychiatric diseases among patients with psoriasis in Korea: A 12‐year nationwide population‐based cohort study
The association between psoriasis and risk of psychiatric diseases has not been thoroughly evaluated in a large longitudinal cohort of the Asian population. We conducted a nationwide cohort study encompassing more than 1.6 million Koreans with a 12‐year follow‐up period. Patients were considered to be in the psoriasis cohort if they had an incident diagnostic code for psoriasis and included patients were followed up until they developed any psychiatric disease. In adjusted models, psoriasis patients (n = 10 868) were at an 18% increased risk for depression (hazard ratio [HR], 1.18; 95% confidence interval [CI], 1.09–1.26), 16% for anxiety disorders (HR, 1.16; 95% CI, 1.08–1.26), and 21% for somatoform disorders (HR, 1.21; 95% CI, 1.08–1.34) compared with the referent cohort (n = 1 620 055). Patients with moderate‐to‐severe psoriasis had a higher risk of developing depression and somatoform disorders than patient with mild disease (depression, HR, 1.28; 95% CI, 1.07–1.54 vs HR, 1.17; 95% CI, 1.07–1.27; somatoform disorders, HR, 1.60; 95% CI, 1.26–2.03 vs HR, 1.13; 95% CI, 1.00–1.28). Our results highlight the burden of psychiatric diseases in patients with psoriasis in Korea and suggest that appropriate medical support for possible mental illness is warranted in Asian psoriatic patients.
- 30 August 2021
- Published by Wiley in The Journal of Dermatology
- Vol. 48 (11) , 1763-1771
Risk of psychiatric diseases among patients with psoriasis in Korea: A 12‐year nationwide population‐based cohort study
The association between psoriasis and risk of psychiatric diseases has not been thoroughly evaluated in a large longitudinal cohort of the Asian population. We conducted a nationwide cohort study encompassing more than 1.6 million Koreans with a 12‐year follow‐up period. Patients were considered to be in the psoriasis cohort if they had an incident diagnostic code for psoriasis and included patients were followed up until they developed any psychiatric disease. In adjusted models, psoriasis patients (n = 10 868) were at an 18% increased risk for depression (hazard ratio [HR], 1.18; 95% confidence interval [CI], 1.09–1.26), 16% for anxiety disorders (HR, 1.16; 95% CI, 1.08–1.26), and 21% for somatoform disorders (HR, 1.21; 95% CI, 1.08–1.34) compared with the referent cohort (n = 1 620 055). Patients with moderate‐to‐severe psoriasis had a higher risk of developing depression and somatoform disorders than patient with mild disease (depression, HR, 1.28; 95% CI, 1.07–1.54 vs HR, 1.17; 95% CI, 1.07–1.27; somatoform disorders, HR, 1.60; 95% CI, 1.26–2.03 vs HR, 1.13; 95% CI, 1.00–1.28). Our results highlight the burden of psychiatric diseases in patients with psoriasis in Korea and suggest that appropriate medical support for possible mental illness is warranted in Asian psoriatic patients.
- 31 October 2020
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 184 (4) , 750-753
Classification of facial and truncal segmental vitiligo and its clinical courses including recurrence rate and patterns: a retrospective review of 956 patients
Dear Editor, segmental vitiligo (SV) is a distinct subtype of vitiligo, characterized by unilateral distribution, early age of onset, and stabilization after rapid progression.1‐3. A classification according to distributions could provide valuable clues to the etiology of SV. Although several studies have proposed classification of SV, we attempted to integrate the classification across the entire body using a large number of patients.
- 31 October 2020
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 184 (4) , 750-753
Classification of facial and truncal segmental vitiligo and its clinical courses including recurrence rate and patterns: a retrospective review of 956 patients
Dear Editor, segmental vitiligo (SV) is a distinct subtype of vitiligo, characterized by unilateral distribution, early age of onset, and stabilization after rapid progression.1‐3. A classification according to distributions could provide valuable clues to the etiology of SV. Although several studies have proposed classification of SV, we attempted to integrate the classification across the entire body using a large number of patients.